The most read article published in Vox Sanguinis in March


Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment

Shawn D. Keil, Izabela Ragan, Susan Yonemura, Lindsay Hartson, Nicole K. Dart and Richard Bowen.

Riboflavin and UV light effectively reduces the titre of SARS‐CoV‐2 in both plasma and platelet products to below the limit of detection in tissue culture. The data suggest that the process would be effective in reducing the theoretical risk of transfusion transmitted SARS‐CoV‐2.

First published: April 20, 2020.
Click here to read the article.